The Implications of the Inflation Reduction Act on Medicare Drug Strategies
Wednesday, December 7, 2022, | 2:00 p.m. – 3:00 p.m. Eastern Time
Following the recent passage of the Inflation Reduction Act (IRA), counties now have an opportunity to rethink how they provide prescription drug benefits for Medicare-eligible retirees.
- The practical and strategic implications of the IRA’s changes to Medicare Part D
- The impact of the financing changes on plan design and funding, including:
- Steps you should take now to address the IRA and questions for your actuary